Cutaneous Mycobacterial Infections
Carlos Franco‐Paredesa b, Luis A. Marcosc, Andrés F. Henao‐Martíneza, Alfonso Javier Rodriguez-Moralesd e, Wilmer E. Villamil‐Gómezf, Eduardo Gotuzzog, Alexandro Bonifázh
- aDivision of Infectious Diseases, University of Colorado Denver Anschutz Medical Campus, Denver, Colorado, USA
- bHospital Infantil de México Federico Gómez, Mexico City, Mexico
- cDivision of Infectious Diseases, Department of Medicine and Department of Microbiology and Molecular Genetics, and Global Health Institute, Stony Brook University, Stony Brook, New York, USA
- dPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia
- eUniversidad Privada Franz Tamayo, Cochabamba, Bolivia
- fDepartamento de Infectología, Hospital Universitario de Sincelejo, Sucre, Colombia
- gInstituto de Medicina Tropical Alexander von Humboldt, University Cayetano Heredia, Lima, Peru
- hServicio de Dermatología y Departamento de Micología, Hospital General de México, Mexico City, Mexico
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
, are increasingly recognized pathogens in cutaneous infections associated particularly with plastic surgery and cosmetic procedures. Skin biopsies of cutaneous lesions to identify acid-fast staining bacilli and cultures represent the cornerstone of diagnosis. Additionally, histopathological evaluation of skin biopsy specimens may be useful in identifying leprosy, Buruli ulcer, and cutaneous tuberculosis. Molecular assays are useful in some cases. The treatment for cutaneous mycobacterial infections depends on the specific pathogen and therefore requires a careful consideration of antimicrobial choices based on official treatment guidelines.